Why Is JBS N.V. (NYSE:JBS) Sliding 9.3% in Pre-Market Trade on Tuesday?

Vinay Lochav

10 November 2026 11:44 PM AEDT

Why Is JBS N.V. (NYSE:JBS) Sliding 9.3% in Pre-Market Trade on Tuesday?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

JBS N.V. (NYSE:JBS) is indicated at USD 11.90 pre-market on November 10, 2026, 9.3% below a calculated prior close of USD 13.12, a drop of roughly USD 1.22 per share.
Third-quarter net Revenue edged up 0.6% to USD 22.74 billion, but Net Income fell 72% to USD 164 million from USD 581 million a year earlier.
Adjusted EBITDA dropped 35.6% to USD 1.18 billion from USD 1.83 billion, and the Margin narrowed to 5.2% from 8.1% in the prior-year quarter.
Net Leverage increased to 3.54 times from 2.39 times, while free Cash Flow was negative USD 167 million versus positive USD 384 million a year earlier.

What Moved JBS N.V. in Pre-Market Trade (down 9.3%)

The company published third-quarter 2026 results on November 9, 2026, and an Earnings Call is set for November 10, 2026. Published coverage put reported Earnings Per Share at USD 0.15, below analyst expectations, even though revenue of USD 22.74 billion beat estimates. Net Debt stood at about USD 19.3 billion at the end of September, against total Liquidity of USD 8.2 billion. Debt carries an average Maturity of 14.4 years and an average cost of 5.8%, and nothing material falls due within five years. In pre-market trade the shares changed hands at USD 11.90, a 9.3% decline from the calculated Monday close of USD 13.12.

The Reasoning: Margins, Leverage and Segment Results

The catalyst is the earnings release. North American beef adjusted EBITDA was negative USD 2 million under IFRS, compared with a loss of USD 42 million a year earlier, and positive USD 21 million under U.S. GAAP. Its monthly Operating Margin improved from negative 2.9% in July to 3.9% in September. JBS Brazil fell 54% to USD 141 million, with margin at 3.4% versus 7.4%, which the company linked to the exhausted 2026 China export Quota and higher cattle prices. Pilgrim's Pride dropped 39.9% to USD 462 million and U.S. pork fell 83% to USD 37 million, while Seara rose 2.5% to USD 331 million on revenue up 6.4% to USD 2.51 billion. As general background, leverage rises mechanically when trailing EBITDA shrinks, and earnings misses often prompt position cuts in thin pre-market trade.

Valuation, Liquidity and Risks Around JBS N.V. in Pre-Market

A verified market capitalisation, average Volume and 52-week range were unavailable in the research window, so none is quoted. Simple arithmetic on net debt of USD 19.3 billion and the 5.8% average cost implies roughly USD 1.12 billion of annual interest on net debt alone, calculated. Management pointed to firmer beef conditions in the fourth quarter, citing renewed Chinese Demand linked to the 2027 Import quota and seasonally stronger consumption in Brazil. Pre-market volume is thin, spreads can be wide, and a small number of trades can move the indicated price. The earnings call on November 10, 2026 may shift sentiment before the 9:30 a.m. ET open, so the pre-market level could reverse and says nothing about later sessions.

Where Things Stand

JBS N.V. (NYSE:JBS) is 9.3% lower in pre-market trade on Tuesday after third-quarter profit fell 72% to USD 164 million, adjusted EBITDA dropped 35.6% to USD 1.18 billion and net leverage climbed to 3.54 times. Revenue of USD 22.74 billion rose only 0.6%. The pre-market quote of USD 11.90 is thinly traded, so it signals sentiment rather than a settled value. The next datapoints are the November 10, 2026 call and the cash open.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.